326 related articles for article (PubMed ID: 29400653)
1. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices.
Weise FK; Bordignon S; Perrotta L; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
EuroIntervention; 2018 Apr; 13(18):e2138-e2146. PubMed ID: 29400653
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
4. Decennial Analysis of Interventional Left Atrial Appendage Closure.
Schmidt B; Bordignon S; Fuernkranz A; Perrotta L; Scherer D; Chun KRJ
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):840-844. PubMed ID: 25930020
[TBL] [Abstract][Full Text] [Related]
5. Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.
Maksym J; Mazurek T; Kochman J; Grygier M; Kapłon-Cieślicka A; Marchel M; Lodziński P; Piątkowski R; Wilimski R; Czub P; Fojt A; Karolczak N; Hendzel P; Opolski G
Kardiol Pol; 2018; 76(2):459-463. PubMed ID: 29350390
[TBL] [Abstract][Full Text] [Related]
6. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet effects of aspirin and clopidogrel after left atrial appendage (LAA) occluder implantation.
Dannenberg L; Mourikis P; Naguib D; Zako S; Helten C; M'Pembele R; Trojovsky K; Konsek D; Wolff G; Brockmeyer M; Schulze V; Levkau B; Hohlfeld T; Zeus T; Kelm M; Polzin A
Int J Cardiol; 2019 Jan; 275():95-100. PubMed ID: 30509374
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure.
Pouru JP; Jaakkola S; Lund J; Biancari F; Saraste A; Airaksinen KEJ
Am J Cardiol; 2019 Dec; 124(12):1894-1899. PubMed ID: 31668344
[TBL] [Abstract][Full Text] [Related]
9. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy.
Pracon R; Bangalore S; Dzielinska Z; Konka M; Kepka C; Kruk M; Kaczmarska-Dyrda E; Petryka-Mazurkiewicz J; Bujak S; Solecki M; Pskit A; Dabrowska A; Sieradzki B; Plonski A; Ruzyllo W; Witkowski A; Demkow M
Circ Cardiovasc Interv; 2018 Mar; 11(3):e005997. PubMed ID: 29463510
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of catheter-based left atrial appendage closure in patients with contraindications for long-term anticoagulation.
Seidel A; Parwani AS; Krackhardt F; Huemer M; Attanasio P; Haverkamp W; Pieske B; Boldt LH
Minerva Cardioangiol; 2017 Dec; 65(6):545-552. PubMed ID: 28565887
[TBL] [Abstract][Full Text] [Related]
11. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
[TBL] [Abstract][Full Text] [Related]
12. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
13. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
[TBL] [Abstract][Full Text] [Related]
14. Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device.
Luani B; Genz C; Herold J; Mitrasch A; Mitusch J; Wiemer M; Schmeißer A; Braun-Dullaeus RC; Rauwolf T
BMC Cardiovasc Disord; 2019 May; 19(1):112. PubMed ID: 31092201
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience.
Asmarats L; Masson JB; Pagnotta PA; Cook S; Foresti M; Ibrahim R; Sukiennik A; Sabiniewicz R; Maffeo D; Carballo J; Cruz-González I; Grasso C; Pisano F; Senatore G; Tarantini G; Kasongo A; Chiarito M; Puricel S; Messas N; Moreno-Samos JC; O'Hara G; Rodés-Cabau J
JACC Cardiovasc Interv; 2018 Oct; 11(19):1932-1941. PubMed ID: 30249439
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of left atrial appendage closure in non-valvular atrial fibrillation in patients over 75 years.
Yu J; Chen H; Post F; Muenzel M; Keil T; Hou CR; Zhao M; Meng Z; Jiang L
Heart Vessels; 2019 Nov; 34(11):1858-1865. PubMed ID: 31144099
[TBL] [Abstract][Full Text] [Related]
17. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.
Asmarats L; O'Hara G; Champagne J; Paradis JM; Bernier M; O'Connor K; Beaudoin J; Junquera L; Del Val D; Muntané-Carol G; Côté M; Rodés-Cabau J
Circ Cardiovasc Interv; 2020 Aug; 13(8):e009039. PubMed ID: 32772571
[TBL] [Abstract][Full Text] [Related]
18. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
[TBL] [Abstract][Full Text] [Related]
19. Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness.
Llagostera-Martín M; Cainzos M; Salvatella N; Cubero-Gallego H; Mas-Stachurska A; Sánchez-Carpintero A; Tizón-Marcos H; Calvo-Fernández A; Molina L; Vaquerizo B
Rev Esp Cardiol (Engl Ed); 2024 Feb; 77(2):150-157. PubMed ID: 37879431
[TBL] [Abstract][Full Text] [Related]
20. Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study.
Duthoit G; Silvain J; Marijon E; Ducrocq G; Lepillier A; Frere C; Dimby SF; Popovic B; Lellouche N; Martin-Toutain I; Spaulding C; Brochet E; Attias D; Mansourati J; Lorgis L; Klug D; Zannad N; Hauguel-Moreau M; Braik N; Deltour S; Ceccaldi A; Wang H; Hammoudi N; Brugier D; Vicaut E; Juliard JM; Montalescot G
Circ Cardiovasc Interv; 2020 Jul; 13(7):e008481. PubMed ID: 32674675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
